Compressive Dressing and Pharyngocutaneous Fistula After Primary Total Laryngectomy (TIGHT)
Impact of Compressive Dressing on the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Multicenter Retrospective Observational Study
Pharyngocutaneous fistula (PCF) is one of the most feared complications after total laryngectomy. A compressive neck dressing is often applied after surgery to try to prevent it, but there is no consensus on whether it works or how long it should be kept, and practice varies widely between centers. This multicenter, retrospective, observational study compares the rate of PCF in adult patients with laryngeal squamous cell carcinoma who underwent primary total laryngectomy with direct closure of the hypopharyngeal mucosa and who did or did not receive a postoperative compressive dressing. It also examines whether the duration of the dressing affects the risk of fistula and how fistulas were managed in the two groups. All data are collected from existing medical records; no additional treatment or examination is performed.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
PCF occurs in about 14% of primary total laryngectomies and about 28% of salvage procedures. It is associated with prolonged hospital stay, higher costs, delayed adjuvant treatment, and further complications. No study has directly compared patients managed with and without a postoperative compressive dressing.
This is a non-profit, multicenter, national, retrospective observational study coordinated by IRCCS Azienda Ospedaliero-Universitaria di Bologna. Consecutive patients who underwent primary total laryngectomy from January 1, 2014 to the study start date are included. All patients were treated according to routine clinical practice at each center. Patients are divided into two groups according to postoperative management: compressive dressing of the cervical region over the neopharyngeal suture (Group A) or no compressive dressing (Group B).
Data are extracted from medical records and entered in pseudonymized form in an electronic case report form (REDCap). Collected variables include demographics, smoking and alcohol use, comorbidities, preoperative laboratory values and inflammatory indices, tumor site and clinical stage, surgical details (neck dissection, thyroidectomy, pharyngeal closure technique, salivary stent, primary voice prosthesis), postoperative antibiotic protocol, time to oral feeding, and fistula characteristics and management.
The planned sample size is 950 patients (475 per group), which provides 80% power to detect a 6.0% difference in fistula rate between groups, assuming a baseline rate of 14.3% in the group without compressive dressing, using a two-sided Fisher's exact test with alpha 0.05. The primary outcome will be analyzed with Fisher's exact test. Secondary outcomes will be analyzed with logistic and linear regression. Confounding will be addressed with propensity score matching, inverse probability weighting, or covariate adjustment, as appropriate.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Edoardo Serafini, MD, Medical Degree
- Phone Number: +39 051 2145263
- Email: edoardo.serafini3@unibo.it
Study Locations
-
-
-
Bergamo, Italy
- Recruiting
- ASST Papa Giovanni XXIII
-
Contact:
- Giovanni Danesi, Medical Degree
- Phone Number: +39 035 2674398
- Email: gdanesi@asst-pg23.it
-
Bologna, Italy
- Recruiting
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
-
Contact:
- Edoardo Serafini, Medical Degree
- Phone Number: +39 051 2145263
-
Bologna, Italy
- Recruiting
- Ospedale Maggiore Carlo Alberto Pizzardi
-
Contact:
- Luca Amorosa, Medical Degree
- Phone Number: +39 051 6478365
- Email: luca.amorosa@ausl.bologna.it
-
Bolzano, Italy
- Recruiting
- Ospedale Centrale di Bolzano
-
Contact:
- Luca Calabrese, medical degree
- Phone Number: +39 0471 438641
- Email: orlbz@sabes.it
-
Brescia, Italy
- Recruiting
- ASST degli Spedali Civili di Brescia
-
Contact:
- Cesare Piazza, Medical Degree
- Phone Number: +39 030 3995319
- Email: cesare.piazza@unibs.it
-
Candiolo, Italy
- Recruiting
- IRCCS Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia
-
Contact:
- Stefano Bondi, Medical Degree
- Phone Number: +39 011 9933405
- Email: stefano.bondi@ircc.it
-
Cesena, Italy
- Recruiting
- Ospedale M. Bufalini
-
Contact:
- Massimo Magnani, Medical Degree
- Phone Number: +39 0541 933458
- Email: massimo.magnani@auslromagna.it
-
Florence, Italy
- Recruiting
- Azienda Ospedaliero-Universitaria Careggi
-
Contact:
- Giandomenico Maggiore, Medical Degree
- Phone Number: +39 055 7942000
-
Forlì, Italy
- Recruiting
- Ospedale G.B. Morgagni - L. Pierantoni
-
Contact:
- Andrea De Vito, Medical Degree
- Phone Number: +39 0543 73651
- Email: andrea.devito@auslromagna.it
-
Milan, Italy
- Recruiting
- Istituto Nazionale dei Tumori
-
Contact:
- Alberto Deganello, Medical Degree
- Email: alberto.deganello@unimi.it
-
Milan, Italy
- Recruiting
- Ospedale San Raffaele
-
Contact:
- Andrea Galli
- Phone Number: +390226438446
- Email: salerno.emilio@hsr.it
-
Contact:
- Mario Bussi, medical degree
- Email: bussi.mario@hsr.it
-
Modena, Italy
- Recruiting
- Azienda Ospedaliero-Universitaria Policlinico di Modena
-
Contact:
- Daniele Marchioni, Medical Degree
- Phone Number: +39 059 4222402
- Email: daniele.marchioni@unimore.it
-
Naples, Italy
- Recruiting
- AORN Ospedale Cardarelli
-
Contact:
- FIlippo Ricciardelli, Medical Degree
- Phone Number: +39 081 7474035
- Email: filippo.ricciardiello@aocardarelli.it
-
Padova, Italy
- Recruiting
- Azienda Ospedale-Università di Padova
-
Contact:
- Piero Nicolai, Medical Degree
- Phone Number: +39 049 8212024
- Email: piero.nicolai@unipd.it
-
Pavia, Italy
- Recruiting
- Fondazione IRCCS Policlinico San Matteo
-
Contact:
- Marco Benazzo, Medical Degree
- Email: marco.benazzo@unipv.it
-
Pescara, Italy
- Recruiting
- Ospedale Santo Spirito
-
Contact:
- Claudio D Caporale, Medical Degree
- Phone Number: +39 085 4252682
- Email: claudiodonadio.caporale@asl.pe.it
-
Ravenna, Italy
- Recruiting
- Ospedale Santa Maria delle Croci
-
Contact:
- Ignacio J Fernandez, Medical Degree
- Email: ignacio.fernandez4@unibo.it
-
Reggio Emilia, Italy
- Recruiting
- Arcispedale Santa Maria Nuova
-
Contact:
- Angelo Ghidini, Medical Degree
- Phone Number: +39 0522 296111
- Email: angelo.ghidini@ausl.re.it
-
Rimini, Italy
- Recruiting
- Ospedale Infermi
-
Contact:
- Marco Trebbi, Medical Degree
- Email: marco.trebbi@auslromagna.it
-
Roma, Italy
- Recruiting
- Fondazione Policlinico Universitario Agostino Gemelli
-
Contact:
- Gaetano Paludetti, Medical Degree
- Email: gaetano.paludetti@policlinicogemelli.it
-
Roma, Italy
- Recruiting
- Ospedale Fatebenefratelli Isola Tiberina - Gemelli Isola
-
Contact:
- Marco Radici, Medical Degree
- Phone Number: +39 06 6837297
- Email: marco.radici@fondazionefatebenefratelli.it
-
Roma, Italy
- Recruiting
- Policlinico Umberto I (Sapienza)
-
Contact:
- Marco De Vincentis, Medical Degree
- Email: marco.devincentiis@uniroma1.it
-
Torino, Italy
- Recruiting
- AOU Città della Salute e della Scienza (Molinette)
-
Contact:
- Giancarlo Pecorari, Medical Degree
- Phone Number: +39 011 6709583
- Email: giancarlo.pecorari@unito.it
-
Trieste, Italy
- Recruiting
- Ospedale di Cattinara
-
Contact:
- Giancarlo Tirelli, Medical Degree
- Phone Number: +39 040 3994933
- Email: tirellig@units.it
-
Verona, Italy
- Recruiting
- Azienda Ospedaliera Universitaria Integrata di Verona
-
Contact:
- Luca Sacchetto, Medical Degree
- Phone Number: +39 045 8127538
- Email: luca.sacchetto@univr.it
-
Vittorio Veneto, Italy
- Recruiting
- Ospedale di Vittorio Veneto - ULSS 2 Marca Trevigiana
-
Contact:
- Andy Bertolin, Medical Degree
- Phone Number: +39 0438 665231
- Email: andy.bertolin@aulss2.veneto.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Consecutive adult patients with squamous cell carcinoma of the larynx who underwent primary total laryngectomy with direct closure of the hypopharyngeal mucosa at the participating Italian otolaryngology centers from January 1, 2014 to the study start date.
Description
Inclusion Criteria:
- Squamous cell carcinoma of the larynx treated with primary total laryngectomy
- Primary closure of the hypopharyngeal mucosa
- Age 18 years or older
- Informed consent to study participation and to personal data processing
- Availability of data on comorbidities, laboratory parameters, and postoperative management
Exclusion Criteria:
- Salvage total laryngectomy
- Previous radiotherapy or chemoradiotherapy to the head and neck
- Previous open surgery of the pharyngolaryngeal region
- Reconstruction with a free or pedicled flap (inlay or onlay)
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: RETROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Compressive dressing (Group A)
Patients who received a postoperative compressive dressing of the cervical region over the neopharyngeal suture after primary total laryngectomy, according to routine clinical practice at the treating center. |
Postoperative compressive dressing applied to the cervical region over the neopharyngeal suture. This is an exposure observed in routine clinical practice; it is not assigned by the study. |
|
No compressive dressing (Group B)
Patients who did not receive a postoperative compressive dressing after primary total laryngectomy, according to routine clinical practice at the treating center. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of pharyngocutaneous fistula
Time Frame: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients who develop a pharyngocutaneous fistula in each group (compressive dressing vs no compressive dressing). |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of pharyngocutaneous fistula by duration of compressive dressing
Time Frame: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients in Group A who develop a pharyngocutaneous fistula, stratified by duration of the compressive dressing (days). |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Time to onset of pharyngocutaneous fistula
Time Frame: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number of days from surgery to diagnosis of pharyngocutaneous fistula in each group. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Type of management of pharyngocutaneous fistula
Time Frame: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients with fistula managed conservatively (compressive dressing) or surgically in each group. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Resolution of pharyngocutaneous fistula
Time Frame: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients whose fistula resolved, by initial group and type of management. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Time to resolution of pharyngocutaneous fistula
Time Frame: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number of days from diagnosis to resolution of the fistula, by initial group and type of management. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Edoardo Serafini, Medical Degree, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Neoplasms by Site
- Neoplasms
- Respiratory Tract Diseases
- Neoplasms by Histologic Type
- Head and Neck Neoplasms
- Neoplasms, Glandular and Epithelial
- Respiratory Tract Neoplasms
- Carcinoma
- Otorhinolaryngologic Diseases
- Otorhinolaryngologic Neoplasms
- Carcinoma, Squamous Cell
- Laryngeal Diseases
- Pathological Conditions, Signs and Symptoms
- Squamous Cell Carcinoma of Head and Neck
- Laryngeal Neoplasms
- Postoperative Complications
Other Study ID Numbers
Other Study ID Numbers
- 162/2025/Oss/AOUBo
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
De-identified individual participant data underlying the published results will be made available upon reasonable request to the Principal Investigator.
IPD Sharing Time Frame
After publication of the study results in a peer-reviewed journal.
IPD Sharing Access Criteria
Data will be shared with researchers who submit a motivated request to the Principal Investigator of the coordinating center (IRCCS Azienda Ospedaliero-Universitaria di Bologna).
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.